Cogstate Ltd. appointed Dr. Richard Mohs as a non- executive director. Dr. Mohs retired from Eli Lilly in 2015, where he held several leadership positions including Vice President for Neuroscience Early Clinical Development and Leader of the Global Alzheimer’s Drug Development Team. Dr. Mohs is currently Chief Scientific Officer for the Global Alzheimer’s Platform (GAP) Foundation. Richard also serves as a consultant to academic institutions, foundations and biopharmaceutical companies, and is a member of the Board of Governors for the Alzheimer’s Drug Discovery Foundation.